Financial Performance - Total revenues for Q2 FY2026 were $1.452 billion, up from $1.358 billion in Q2 FY2025, reflecting a variance of $94 million[3]. - Net income for Q2 FY2026 increased to $128.5 million, compared to $118.5 million in Q2 FY2025, marking a growth of $10 million[3]. - Net income for the twenty-six week period ended December 24, 2025, was $228.0 million, compared to $157.0 million for the same period in 2024, reflecting a year-over-year increase of 45.2%[26]. - Basic net income per share for the thirteen-week period ended December 24, 2025, was $2.92, up from $2.67 in the prior year, marking an increase of 9.3%[21]. - Net income for Q2 26 was $128.5 million, up from $118.5 million in Q2 25, indicating an increase of 8%[38]. - The company reported a year-to-date net income of $228.0 million for Q2 26, compared to $157.0 million in Q2 25, an increase of 45%[38]. Sales Growth - Chili's achieved a 2-year comparable sales growth of +43% and a 7.5% increase in company comparable restaurant sales for Q2 FY2026, with Chili's specifically growing by 8.6%[2][4]. - Comparable restaurant sales for company-owned restaurants increased by 7.5% for Q2 2026 compared to Q2 2025, with Chili's domestic showing an increase of 8.6%[30]. - Chili's franchisees generated sales of approximately $271.9 million in Q2 FY2026, compared to $232.3 million in Q2 FY2025[15]. - Franchise revenues for Q2 26 were $13.2 million, up from $11.9 million in Q2 25, reflecting a growth of 11%[34]. Operating Income - Operating income for the twenty-six week period ended December 24, 2025, was $286.3 million, compared to $212.4 million for the same period in 2024, representing a 34.7% increase[21]. - Chili's operating income for Q2 26 was $200.0 million, up from $175.1 million in Q2 25, representing an increase of 14%[34]. - Maggiano's operating income for Q2 26 was $15.0 million, compared to $28.2 million in Q2 25, reflecting a decrease of 46%[34]. Guidance and Projections - Full year FY2026 revenue guidance has been raised to $5.76 billion - $5.83 billion, up from the previous guidance of $5.60 billion - $5.70 billion[7]. - Net income per diluted share guidance, excluding special items, has been increased to $10.45 - $10.85 from $9.90 - $10.50[7]. - The company plans to open 32-38 new franchise restaurants in the fiscal year, with 24-28 of those being Chili's international locations[29]. Expenses and Liabilities - Interest expenses decreased to $10.7 million in Q2 26 from $14.7 million in Q2 25, a reduction of 27%[38]. - Depreciation and amortization increased to $54.6 million in Q2 26 from $47.7 million in Q2 25, a rise of 14%[38]. - The company reported total current liabilities of $669.7 million as of December 24, 2025, a slight decrease from $675.6 million in the previous period[23]. Cash Flow and Assets - Cash flows from operating activities for the twenty-six week period ended December 24, 2025, were $339.7 million, compared to $281.0 million for the same period in 2024, indicating a 20.8% increase[26]. - Total assets as of December 24, 2025, were $2,749.2 million, up from $2,678.6 million as of June 25, 2025, reflecting a growth of 2.6%[23]. Tax and External Factors - The effective income tax rate for Q2 FY2026 was 18.7%, lower than the statutory rate of 21.0% due to the leverage of the FICA tip credit[11]. - The company anticipates a negative impact of approximately $20 million in revenues and a decrease of $0.15 in net income per diluted share due to Winter Storm Fern[6]. Restaurant Operations - The total number of company-owned restaurants as of December 24, 2025, was 1,160, a decrease from 1,164 in the previous year, with projected openings of 6 for the full fiscal year[29]. - The non-GAAP restaurant operating margin for Chili's was 19.1% in Q2 26, an increase from 18.7% in Q2 25[34]. - Adjusted EBITDA for Q2 26 was $223.5 million, compared to $215.8 million in Q2 25, showing a growth of 4%[38]. - The company emphasizes that restaurant operating margin is a useful metric for evaluating restaurant-level operating efficiency, despite being a non-GAAP measure[35].

January 28, 2026 Press Release | Source: | Farmers National Banc Corp. | | --- | --- | | | Kevin J. Helmick, President and CEO | | | 20 South Broad Street, P.O. Box 555 | | | Canfield, OH 44406 | | | 330.533.3341 | | | Email: exec@farmersbankgroup.com | FARMERS NATIONAL BANC CORP. ANNOUNCES EARNINGS FOR FOURTH QUARTER OF 2025 CANFIELD, Ohio (January 28, 2026) – Farmers National Banc Corp. ("Farmers" or the "Company") (NASDAQ: FMNB) today announced net income of $14.6 million, or $0.39 per diluted share, for ...

Exhibit 99.1 11011 Sunset Hills Road Reston, Virginia 20190 www.gd.com News Contact: Jeff A. Davis Tel: 703 876 3483 press@generaldynamics.com General Dynamics Reports Fourth-Quarter and Full-Year 2025 Financial Results January 28, 2026 RESTON, Va. – General Dynamics (NYSE: GD) today reported quarterly net earnings of $1.1 billion on revenue of $14.4 billion. Diluted earnings per share (EPS) was $4.17. For the full year, net earnings were $4.2 billion, up 11.3% from 2024, on revenue of $52.6 billion, up 10. ...

Financial Performance - Net income for Q4 2025 was $21.5 million, or $1.11 per diluted share, compared to $21.9 million, or $1.13 per diluted share in Q3 2025[3] - For the year ended December 31, 2025, net income totaled $80.9 million, with diluted earnings per share of $4.18, compared to $22.1 million and $1.48 for 2024[3] - Basic earnings per share increased to $1.12 for Q4 2025, compared to $0.72 in Q4 2024, demonstrating significant growth in profitability[29] - Net income for the twelve months ended December 31, 2025, reached $80,855,000, significantly higher than $22,050,000 in 2024, marking a growth of 267.5%[33] - Net income for the quarter was $21,491 thousand, a significant increase from $13,684 thousand in the same quarter of the previous year, representing a growth of 56.8%[51] Income and Expenses - Noninterest income rose by $1.0 million to $14.4 million in Q4 2025, driven by growth in wealth management and swap fees[18] - Noninterest expenses increased by $1.1 million to $37.4 million in Q4 2025, primarily due to higher healthcare and professional service costs[20] - Total noninterest expenses decreased to $37,355,000 in Q4 2025 from $42,930,000 in Q4 2024, a reduction of 12.5%[33] - Adjusted noninterest expense for the twelve months ended December 31, 2025, was $146,825,000, compared to $120,396,000 in 2024, an increase of 22%[54] Asset and Loan Growth - Total loans increased by $41.0 million, or approximately 4% annualized, from Q3 2025 to Q4 2025, totaling $4.0 billion[5] - Total assets increased to $5.542 billion at December 31, 2025, compared to $5.442 billion at December 31, 2024, indicating growth in the asset base[30] - Total interest-earning assets increased to $4,995,061,000 in 2025 from $3,991,148,000 in 2024, reflecting a growth of approximately 25.2%[37] - Average balances of loans increased to $3,945,723,000 in 2025 from $3,150,425,000 in 2024, a growth of approximately 25.3%[37] Capital and Equity - Shareholders' equity increased to $591.5 million at December 31, 2025, up from $571.9 million at September 30, 2025, driven by net income of $21.5 million and other comprehensive income of $2.3 million[24] - The tangible book value per common share rose to $25.21 at December 31, 2025, compared to $24.12 at September 30, 2025, reflecting a stronger capital position[25] - The Company’s total risk-based capital ratio improved to 13.3% at December 31, 2025, compared to 12.4% at December 31, 2024, reflecting enhanced capital adequacy[30] Profitability Ratios - The return on average assets was 1.55% and return on average equity was 14.73% for Q4 2025, compared to 1.60% and 15.72% in Q3 2025[3] - The Company reported a return on average tangible common equity of 18.15% for Q4 2025, down from 19.70% in Q3 2025, attributed to an increase in average shareholders' equity[25] - Return on average tangible equity was 18.15% for the quarter ended December 31, 2025, compared to 13.62% a year earlier, indicating improved profitability[51] Dividend Information - The Board of Directors declared a cash dividend of $0.30 per common share, representing a $0.03 increase from the previous quarter[3] - Dividends paid per share increased to $0.27 in Q4 2025 from $0.23 in Q4 2024, reflecting a growth of 17.4%[34] Credit Quality - Classified loans decreased by $5.7 million to $58.4 million at December 31, 2025, while non-accrual loans increased to $28.0 million[17] - The allowance for credit losses to total loans ratio was 1.19% as of December 31, 2025, compared to 1.24% a year earlier, indicating improved credit quality[45] - The provision for credit losses on loans was $75,000 in Q4 2025, a significant decrease from $2,617,000 in Q4 2024[33] Market and Economic Factors - The company emphasizes that forward-looking statements are based on current expectations and are subject to risks and uncertainties that could lead to actual results differing materially from those anticipated[57] - Factors affecting future performance include interest rate changes, economic conditions, competition, and changes in consumer behavior[57] - The company warns that reliance on forward-looking statements should be limited, as they may not be updated publicly after the date made[58]

Financial Performance - In Q4 2025, M/I Homes reported a pre-tax income of $80.6 million and a net income of $64.0 million, down from $170.6 million and $133.5 million respectively in Q4 2024[5]. - For the full year 2025, pre-tax income was $526.6 million, a decrease of 28% from $733.6 million in 2024, with net income at $402.9 million compared to $563.7 million in 2024[5]. - Total revenue for 2025 was $4.4 billion, a decrease of 2% from $4.5 billion in 2024[6]. - For the three months ended December 31, 2025, net income was $63,971,000, a decrease of 52% compared to $133,469,000 for the same period in 2024[21]. - Adjusted EBITDA for the twelve months ended December 31, 2025, was $608,456,000, down 20.7% from $767,450,000 in 2024[21]. - Adjusted net income for the twelve months ended December 31, 2025, was $447,958,000, a decrease from $563,725,000 in 2024[25]. Contracts and Deliveries - New contracts in Q4 2025 increased by 9% to 1,921, while homes delivered decreased by 4% to 2,301 compared to Q4 2024[6]. - New contracts for the three months ended December 31, 2025, totaled 1,921 homes, representing a 9% increase from 1,759 homes in the same period of 2024[23]. - Homes delivered in the three months ended December 31, 2025, were 2,301, a decrease of 4% from 2,402 homes delivered in the same period of 2024[23]. Backlog and Inventory - Homes in backlog decreased by 29% to 1,809 units, with a sales value of $989.9 million, down from $1.4 billion in 2024[7]. - The total backlog as of December 31, 2025, was 1,809 units with an average sales price of $547,000, compared to 2,531 units with an average sales price of $553,000 as of December 31, 2024[23]. Shareholder and Equity Information - Shareholders' equity reached a record $3.2 billion, with a book value per share of $123, and a return on equity of 13%[8]. - M/I Homes repurchased $50 million of stock in Q4 2025 and $202 million for the full year[6]. Operational Metrics - The company ended 2025 with 232 active communities, an increase from 220 in 2024, and a cancellation rate of 10% in Q4 2025, down from 14% in Q4 2024[7]. - The average sales price in backlog decreased by 1% to $547,000 compared to $553,000 in 2024[7]. - Cash used in operating activities for the three months ended December 31, 2025, was $(8,707,000), compared to cash provided of $104,395,000 in the same period of 2024[19]. - Land purchases for the twelve months ended December 31, 2025, amounted to $523,689,000, an increase from $472,937,000 in 2024[19]. - Financial services pre-tax income for the twelve months ended December 31, 2025, was $55,656,000, up from $49,682,000 in 2024[19]. - The company reported a total of 25,652 lots owned and 24,329 lots under contract as of December 31, 2025, compared to 23,836 lots owned and 28,320 lots under contract as of December 31, 2024[23]. Debt and Financial Health - The company maintained a homebuilding debt to capital ratio of 18% and zero borrowings under its $900 million credit facility[8].

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended December 28, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number: 000-20322 Starbucks Corporation (Exact Name of Registrant as Specified in its Charter) Washington 91-1325671 (State or Ot ...

Exhibit 99.1 Starbucks Reports Q1 Fiscal Year 2026 Results Q1 Comparable Store Sales Accelerate to 4% Globally and in the U.S., Led by Transactions Company Delivers U.S. Comparable Transaction Growth for the First Time in Eight Quarters Q1 Consolidated Net Revenues Up 6% to $9.9 Billion Q1 GAAP EPS $0.26, Non-GAAP EPS $0.56 Company Introduces Fiscal Year 2026 Guidance SEATTLE; January 28, 2026 – Starbucks Corporation (Nasdaq: SBUX) today reported financial results for its 13-week fiscal first quarter ended ...

Exhibit 99.1 295 Woodcliff Drive, Suite 202, Fairport, New York 14450 CONTACT: Investors and Media: Felix Veksler Vice President, Investor Relations ir@monro.com FOR IMMEDIATE RELEASE MONRO, INC. ANNOUNCES THIRD QUARTER FISCAL 2026 FINANCIAL RESULTS FAIRPORT, N.Y. – January 28, 2026 – Monro, Inc. (Nasdaq: MNRO), a leading provider of automotive repair and tire services, today announced financial results for its third quarter ended December 27, 2025. Third Quarter Results Sales for the third quarter of the f ...

Financial Performance - U.S. Consumer net sales for the first quarter were $328.5 million, reflecting a 4% decrease compared to the prior year[22] - GAAP gross margin rate improved by 90 basis points to 25.0%, while non-GAAP adjusted gross margin rate also improved by 90 basis points to 25.4%[8] - GAAP net loss from continuing operations was $0.83 per share, an improvement of $0.32 per share compared to the prior year[8] - Non-GAAP adjusted EBITDA for the quarter was $3.0 million, an increase of $2.1 million over the prior year[8] - The U.S. Consumer segment reported a segment profit of $9.0 million, down 8% from the previous year[22] - The net loss from continuing operations for the three months ended December 27, 2025, was $47.8 million, compared to a net loss of $66.1 million in the same period of 2024[26] - Adjusted EBITDA for the three months ended December 27, 2025, was $3.0 million, up from $0.9 million in the same period of 2024[26] - The company reported a diluted net loss per common share from continuing operations of $0.83 for the three months ended December 27, 2025, compared to $1.15 in the same period of 2024[26] Guidance and Future Expectations - The company reaffirmed its fiscal 2026 guidance, including non-GAAP adjusted net income per share from continuing operations projected between $4.15 and $4.35[15] - The company anticipates free cash flow of $275 million, which will drive the leverage ratio down to the high 3's[15] Asset and Liability Management - Total assets decreased to $3,034.0 million in December 2025 from $3,170.2 million in December 2024, a decline of approximately 4.3%[24] - Total current assets increased to $1,257.2 million in December 2025, compared to $940.3 million in September 2025, reflecting a growth of approximately 33.7%[24] - Long-term debt decreased to $2,250.2 million in December 2025 from $2,636.9 million in December 2024, a reduction of approximately 14.7%[24] - The current portion of debt increased significantly to $278.3 million in December 2025 from $54.6 million in December 2024[24] - The total liabilities decreased to $3,534.6 million in December 2025 from $3,649.7 million in December 2024, a decline of approximately 3.1%[24] Discontinued Operations - The planned divestiture of the Hawthorne subsidiary is expected to close in the fiscal second quarter, with the business classified as a discontinued operation[2] - The Company has classified the Hawthorne business as held for sale, impacting its financial statements for all periods presented[43] - Effective in the first quarter of fiscal 2026, the results of operations for the Hawthorne business will be reflected as a discontinued operation[43] - The Company incurred a loss from discontinued operations of $77.2 million for the three months ended December 27, 2025, compared to $3.4 million in the same period of 2024[42] - The decision to classify the Hawthorne business as held for sale was made during the three months ended December 27, 2025[43] Accounting and Reporting Practices - The Company does not provide a GAAP outlook due to the unpredictability of certain excluded items, which could significantly impact GAAP results[43] - Forward-looking non-GAAP measures are presented, but no reconciliation to GAAP measures is provided due to unreasonable efforts[43] - The reclassification of the Hawthorne business affects the Condensed Consolidated Balance Sheets for all periods presented[43] - Management does not forecast many of the excluded items for internal use, complicating the creation of a GAAP outlook[43] - The Company emphasizes that changes in excluded items are dependent on future events that are less predictable[43] - The classification of the Hawthorne business aligns with the criteria for being held for sale as per accounting standards[43] - The Company aims to ensure the accuracy of its financial reporting while navigating the complexities of non-GAAP measures[43] Shareholder Returns - A share repurchase program of up to $500 million has been approved, expected to commence in late 2026[3] Leverage and Financial Ratios - Net leverage improved to 4.03x, a reduction of 0.49x compared to the previous year[8]

EXHIBIT 99.1 Teva to Present at the 44th Annual J.P. Morgan Healthcare Conference: Pivot to Growth Strategy Delivering Growth and Transforming through Innovation Richard Francis, Teva's President and CEO, will present at the 44th Annual J.P. Morgan Healthcare Conference on Tuesday, January 13, 2026, at 8:15 A.M. Pacific Time (11:15 A.M. Eastern Time) TEL AVIV, Israel, Jan. 11, 2026 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) will present its ongoing transformation and expec ...